Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • Delivering Value for Patients Now and In the Future

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    LaKeisha_Annual_Report_1280_960_1
    Since 2015, our Patient Value Strategy has been the driver of UCB’s approach to delivering value for patients. Our operational model puts patients and their individual experiences at the heart of everything we do – from discovery to development to delivery.

    Read more

  • Like
  • Recognizing Patients Who Inspire Us

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    spencer.1280x960
    At UCB, we innovate to bring differentiated solutions with unique outcomes that help specific patients achieve their goals. To do this, we always start with the patient – listening to their experiences, what they value, and what their needs are – keeping them at the heart of everything we do. In honor of Patient Recognition Week, check out a few stories that inspire us to continue to invest in research, expand our scientific understanding, and deliver solutions that provide patients the best individual experience.

    Read more

  • Like
  • UCB: A Decade in Review

    UCB Duane Headshot Blog
    Over the last 10 years, UCB has delivered breakthrough medicines to improve the lives of patients. President and Head of U.S. Operations Duane Barnes, writes about how UCB aspires to innovate for patients over the next decade as we look toward 2030.

    Read more

  • Like
  • UCB’s U.S. Neurology Team Wins EyeForPharma Award for Agile Transformation

    epf.1280x960














    (L to R): Members of the U.S. Neurology Internal Engine Stephanie Hunter-Banks, Jim Hlavenka, Brad Chapman, Trenton Merideth, Tonja Pitts

    UCB’s U.S. Neurology team won a 2019 EyeForPharma award last night in the “Most Promising Agile Transformation” category, which recognizes an experimental initiative that has the potential to disrupt the status quo. The award was presented for the team’s Internal Engine transformation, fulfilling the award criteria of showing agility through rapid creation of a service that touched real customers before being refined and assessed through smart measurement.

    Read more

  • Like
  • Patient-Driven Approach to Innovation

    patient_driven_design_blog_size
    At UCB, our approach to innovation is designed around the patient and their individual experience. Every day, Chris Protos, Solution Enablement Lead, wakes up and thinks about ways we can continue to keep patients at the heart of everything we do. Hear more from Chris about how we’re addressing gaps in patient care through our patient-driven approach to innovation by watching the video below.

    Read more

  • Like
  • Press Release: UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

    UCB_LOGO_1280x960
    UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

    Read more

  • Like
  • UCB Addresses Urgent Unmet Need for Patients with Epilepsy

    MikeDavis Quote Headshot BlogPost_1
    As UCB attends the 2019 American Epilepsy Society meeting in Baltimore, Maryland this week, Mike Davis, Head of Neurology in the U.S., talks about the long way to go in managing epilepsy, and how UCB is committed to closing this gap by bringing new solutions to market. Read the article on LinkedIn.

    Read more

  • Like
  • Press Release: Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®

    UCB_LOGO_1280x960
    Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®

    Read more

  • Like
  • Press Release: UCB Presents New Data Demonstrating Commitment to Epilepsy at 2019 American Epilepsy Society Meeting

    UCB_LOGO_1280x960
    • 14 scientific presentations will cover UCB’s pipeline assets, epilepsy-specific research, and licensed medicines, including NAYZILAM, now available for the acute treatment of seizure clusters in epilepsy patients 12 years of age and older
    • Friday evening symposium on “Epilepsy Treatment Update for Patients Suffering from Seizure Clusters” includes Epilepsy Foundation’s project on seizure emergencies and a panel discussion on the misconceptions around seizure clusters

    Read more

  • Like
  • Spencer’s Story: What to Know About Seizure Clusters

    spencer.1280x960




    At just one day old, Spencer, born in Greenville, South Carolina, had his first seizure, a sudden, uncontrolled electrical disturbance in the brain that usually causes a change in behavior.1,2

    Read more

  • Like